Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, 88100 Catanzaro, Italy.
Annunziata Hospital, 87100 Cosenza, Italy.
Cells. 2021 Feb 2;10(2):303. doi: 10.3390/cells10020303.
New insights into the field of iron metabolism within the tumor microenvironment have been uncovered in recent years. Iron promotes the production of reactive oxygen species, which may either trigger ferroptosis cell death or contribute to malignant transformation. Once transformed, cancer cells divert tumor-infiltrating immune cells to satisfy their iron demand, thus affecting the tumor immunosurveillance. In this review, we highlight how the bioavailability of this metal shapes complex metabolic pathways within the tumor microenvironment and how this affects both tumor-associated macrophages and tumor-infiltrating lymphocytes functions. Furthermore, we discuss the potentials as well as the current clinical controversies surrounding the use of iron metabolism as a target for new anticancer treatments in two opposed conditions: i) the "hot" tumors, which are usually enriched in immune cells infiltration and are extremely rich in iron availability within the microenvironment, and ii) the "cold" tumors, which are often very poor in immune cells, mainly due to immune exclusion.
近年来,人们对肿瘤微环境中铁代谢领域有了新的认识。铁促进活性氧的产生,这可能触发铁死亡细胞死亡或导致恶性转化。一旦发生转化,癌细胞会将肿瘤浸润免疫细胞转移到满足其铁需求,从而影响肿瘤免疫监视。在这篇综述中,我们强调了这种金属的生物利用度如何塑造肿瘤微环境中的复杂代谢途径,以及这如何影响肿瘤相关巨噬细胞和肿瘤浸润淋巴细胞的功能。此外,我们讨论了在两种相反的情况下,即:i)“热”肿瘤,通常富含免疫细胞浸润,并且微环境中铁的可用性极高;ii)“冷”肿瘤,通常免疫细胞很少,主要是由于免疫排斥,将铁代谢作为新的抗癌治疗靶点的潜力和当前临床争议。